PHIO PHARMACEUTICALS CORP. Earnings Per Share, Basic and Diluted
PHIO PHARMACEUTICALS CORP. (PHIO) reported Earnings Per Share, Basic and Diluted of -$1.04 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-22.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-22
- PHIO PHARMACEUTICALS CORP. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.28.
- PHIO PHARMACEUTICALS CORP. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.20.
- PHIO PHARMACEUTICALS CORP. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.32.
- PHIO PHARMACEUTICALS CORP. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.40.
- PHIO PHARMACEUTICALS CORP. earnings per share, basic and diluted for fiscal 2021 was -$1.04.
- PHIO PHARMACEUTICALS CORP. earnings per share, basic and diluted for fiscal 2020 was -$1.92.
- PHIO PHARMACEUTICALS CORP. earnings per share, basic and diluted for fiscal 2019 was -$19.33.
- PHIO PHARMACEUTICALS CORP. earnings per share, basic and diluted for fiscal 2018 was -$57.46.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$1.04 10-K · filed 2022-03-22 | |||||||
| 2021-09-30 | -$0.28 10-Q · filed 2021-11-10 | -$0.78 10-Q · filed 2021-11-10 | ||||||
| 2021-06-30 | -$0.20 10-Q · filed 2021-08-12 | -$0.50 10-Q · filed 2021-08-12 | ||||||
| 2021-03-31 | -$0.32 10-Q · filed 2021-05-13 | |||||||
| 2020-12-31 | -$1.92 10-K · filed 2022-03-22 | |||||||
| 2020-09-30 | -$0.40 10-Q · filed 2021-11-10 | -$1.51 10-Q · filed 2021-11-10 | ||||||
| 2020-06-30 | -$0.34 10-Q · filed 2021-08-12 | -$1.19 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | -$1.33 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | -$19.33 10-K · filed 2021-03-25 | |||||||
| 2019-09-30 | -$4.53 10-Q · filed 2020-11-10 | -$0.08 10-Q · filed 2019-11-12 | -$14.70 10-Q · filed 2020-11-10 | -$0.27 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | -$4.62 10-Q · filed 2020-08-12 | -$0.08 10-Q · filed 2019-08-12 | -$10.23 10-Q · filed 2020-08-12 | -$0.19 10-Q · filed 2019-08-12 | ||||
| 2019-03-31 | -$5.71 10-Q · filed 2020-05-12 | -$0.10 10-Q · filed 2019-05-14 | ||||||
| 2018-12-31 | -$57.46 10-K · filed 2020-03-26 | -$1.04 10-K · filed 2019-03-27 | ||||||
| 2018-09-30 | -$0.34 10-Q · filed 2019-11-12 | -$1.54 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | -$0.46 10-Q · filed 2019-08-12 | -$1.25 10-Q · filed 2019-08-12 | ||||||
| 2018-03-31 | -$0.90 10-Q · filed 2019-05-14 | |||||||
| 2017-12-31 | -$5.52 10-K · filed 2019-03-27 | |||||||
| 2017-09-30 | -$1.05 10-Q · filed 2018-11-14 | -$0.11 10-Q · filed 2017-11-08 | -$4.71 10-Q · filed 2018-11-14 | -$0.47 10-Q · filed 2017-11-08 | ||||
| 2017-06-30 | -$1.12 10-Q · filed 2018-08-14 | -$0.11 10-Q · filed 2017-08-10 | -$3.71 10-Q · filed 2018-08-14 | -$0.37 10-Q · filed 2017-08-10 | ||||
| 2017-03-31 | -$2.65 10-Q · filed 2018-05-10 | -$0.27 10-Q · filed 2017-05-11 | ||||||
| 2016-12-31 | -$6.02 derived: net income ÷ weighted average shares · filed 2018-03-26 | -$9.52 derived: net income ÷ weighted average shares · filed 2018-03-26 | -$12.97 derived: net income ÷ weighted average shares · filed 2018-03-26 | -$16.41 10-K · filed 2018-03-26 | -$1.64 10-K · filed 2017-03-30 | |||
| 2016-09-30 | -$0.34 10-Q · filed 2016-11-10 | -$6.75 derived: net income ÷ weighted average shares · filed 2018-03-26 | -$10.16 10-Q/A · filed 2018-03-26 | -$1.02 10-Q · filed 2016-11-10 | -$4.36 derived: net income ÷ weighted average shares · filed 2018-03-26 | |||
| 2016-06-30 | -$3.38 10-Q/A · filed 2018-03-26 | -$0.34 10-Q · filed 2016-08-11 | -$6.80 10-Q/A · filed 2018-03-26 | -$0.68 10-Q · filed 2016-08-11 | -$2.70 derived: net income ÷ weighted average shares · filed 2018-03-26 | -$2.66 derived: net income ÷ weighted average shares · filed 2018-03-26 | ||
| 2016-03-31 | -$3.41 10-Q/A · filed 2018-03-26 | -$0.34 10-Q · filed 2016-05-12 | -$1.35 derived: net income ÷ weighted average shares · filed 2018-03-26 | -$1.61 derived: net income ÷ weighted average shares · filed 2018-03-26 | -$2.11 derived: net income ÷ weighted average shares · filed 2018-03-26 | |||
| 2015-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2017-03-30 | -$0.78 derived: net income ÷ weighted average shares · filed 2017-03-30 | -$1.25 derived: net income ÷ weighted average shares · filed 2017-03-30 | -$2.10 10-K · filed 2017-03-30 | -$0.21 10-K · filed 2016-03-30 | |||
| 2015-09-30 | -$0.38 10-Q · filed 2016-11-10 | -$0.04 10-Q · filed 2015-11-12 | -$0.86 derived: net income ÷ weighted average shares · filed 2016-11-10 | -$1.76 10-Q · filed 2016-11-10 | -$0.18 10-Q · filed 2015-11-12 | -$1.22 derived: net income ÷ weighted average shares · filed 2016-11-10 | ||
| 2015-06-30 | -$0.50 10-Q · filed 2016-08-11 | -$0.05 10-Q · filed 2015-08-12 | -$1.56 10-Q · filed 2016-08-11 | -$0.16 10-Q · filed 2015-08-12 | -$0.86 derived: net income ÷ weighted average shares · filed 2016-08-11 | -$0.97 derived: net income ÷ weighted average shares · filed 2016-08-11 | ||
| 2015-03-31 | -$1.32 10-Q · filed 2016-05-12 | -$0.13 10-Q · filed 2015-05-13 | -$0.50 derived: net income ÷ weighted average shares · filed 2016-05-12 | -$0.64 derived: net income ÷ weighted average shares · filed 2016-05-12 | -$0.87 derived: net income ÷ weighted average shares · filed 2016-05-12 | |||
| 2014-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$0.29 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$0.51 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$0.79 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | -$0.17 10-Q · filed 2015-11-12 | -$0.39 derived: net income ÷ weighted average shares · filed 2015-11-12 | -$0.69 10-Q · filed 2015-11-12 | -$1.00 derived: net income ÷ weighted average shares · filed 2015-11-12 | ||||
| 2014-06-30 | -$0.23 10-Q · filed 2015-08-12 | -$0.54 10-Q · filed 2015-08-12 | -$0.86 derived: net income ÷ weighted average shares · filed 2015-08-12 | -$1.16 derived: net income ÷ weighted average shares · filed 2015-08-12 | ||||
| 2014-03-31 | -$0.32 10-Q · filed 2015-05-13 | -$0.64 derived: net income ÷ weighted average shares · filed 2015-05-13 | -$0.94 derived: net income ÷ weighted average shares · filed 2015-05-13 | -$1.33 derived: net income ÷ weighted average shares · filed 2015-05-13 | ||||
| 2013-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2015-03-30 | -$0.62 derived: net income ÷ weighted average shares · filed 2015-03-30 | -$1.01 derived: net income ÷ weighted average shares · filed 2015-03-30 | -$2.88 10-K · filed 2015-03-30 | ||||
| 2013-09-30 | -$0.30 10-Q · filed 2014-11-13 | -$0.69 derived: net income ÷ weighted average shares · filed 2014-11-13 | -$2.64 10-Q · filed 2014-11-13 | -$3.29 derived: net income ÷ weighted average shares · filed 2014-11-13 | ||||
| 2013-06-30 | -$0.39 10-Q · filed 2014-08-14 | -$2.52 10-Q · filed 2014-08-14 | -$3.26 derived: net income ÷ weighted average shares · filed 2014-08-14 | -$3.95 derived: net income ÷ weighted average shares · filed 2014-08-14 | ||||
| 2013-03-31 | -$2.76 10-Q · filed 2014-05-14 | -$0.09 10-Q · filed 2013-05-15 | -$3.49 derived: net income ÷ weighted average shares · filed 2014-05-14 | -$4.14 derived: net income ÷ weighted average shares · filed 2014-05-14 | -$7.78 derived: net income ÷ weighted average shares · filed 2014-05-14 | |||
| 2012-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2014-03-28 | -$1.05 derived: net income ÷ weighted average shares · filed 2014-03-28 | -$4.77 derived: net income ÷ weighted average shares · filed 2014-03-28 | -$5.62 10-K · filed 2014-03-28 | -$0.19 10-K · filed 2013-03-29 | |||
| 2012-09-30 | -$0.56 10-Q · filed 2013-11-14 | -$0.02 10-Q · filed 2012-11-13 | -$4.38 derived: net income ÷ weighted average shares · filed 2013-11-14 | -$5.32 10-Q · filed 2013-11-14 | -$0.18 10-Q · filed 2012-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2013-11-14 | ||
| 2012-06-30 | -$4.13 10-Q · filed 2013-08-14 | -$0.13 10-Q · filed 2012-08-14 | -$5.20 10-Q · filed 2013-08-14 | -$0.16 10-Q · filed 2012-08-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2013-08-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2013-08-14 | ||
| 2012-03-31 | -$0.04 10-Q · filed 2013-05-15 | -$0.00 derived: net income ÷ weighted average shares · filed 2013-05-15 | -$0.00 derived: net income ÷ weighted average shares · filed 2013-05-15 | -$0.00 derived: net income ÷ weighted average shares · filed 2013-05-15 | ||||
| 2011-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2013-03-29 | -$0.10 derived: net income ÷ weighted average shares · filed 2013-03-29 | -$0.15 derived: net income ÷ weighted average shares · filed 2013-03-29 | -$0.28 10-K · filed 2013-03-29 | ||||
| 2011-09-30 | -$0.05 10-Q · filed 2012-11-13 | -$0.10 derived: net income ÷ weighted average shares · filed 2012-11-13 | -$0.23 10-Q · filed 2012-11-13 | |||||
| 2011-06-30 | -$0.05 10-Q · filed 2012-08-14 | -$0.19 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |